financetom
Business
financetom
/
Business
/
Nayax Swings to Q1 Earnings, Revenue Rises; 2025 Revenue Guidance Reaffirmed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nayax Swings to Q1 Earnings, Revenue Rises; 2025 Revenue Guidance Reaffirmed
May 26, 2025 6:39 AM

08:14 AM EDT, 05/13/2025 (MT Newswires) -- Nayax ( NYAX ) reported Q1 earnings Tuesday of $0.192 per diluted share, swinging from a loss of $0.147 a year earlier.

Four analysts polled by FactSet expected a loss of $0.01.

Revenue for the quarter ended March 31 was $81.1 million, up from $64 million a year earlier.

Analysts surveyed by FactSet expected $85.1 million.

The company is reaffirming its 2025 revenue guidance of $410 million to $425 million on a constant currency basis. Analysts polled by FactSet expect $410.6 million.

The company's shares were up 1.6% in recent Tuesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China approves CSPC Pharma's RSV vaccine for clinical trials
China approves CSPC Pharma's RSV vaccine for clinical trials
Jul 11, 2024
SHANGHAI, July 12 (Reuters) - China's National Medical Products Administration has given regulatory clearance for CSPC Pharmaceutical Group's ( CHJTF ) respiratory syncytial virus (RSV) vaccine candidate to begin human clinical trials, the drugmaker said. RSV, which shows symptoms similar to a cold but can be fatal for young children and older adults, contributed to 17.6% of one group of...
India Morning Newsletter, July 12
India Morning Newsletter, July 12
Jul 11, 2024
To access a PDF version of this newsletter, please click here If you would like to receive this newsletter via email, please register at: https://solutions.refinitiv.com/MNCIndiaSubscriptionpage For an index of our newsletters click on ...
Australia's ANZ to probe allegations of inflated bond trades, CEO tells staff
Australia's ANZ to probe allegations of inflated bond trades, CEO tells staff
Jul 11, 2024
(Reuters) - Australia's ANZ Group ( ANZGF ) plans to get to the bottom of allegations of misconduct that have been raised against its bond trading operations and will hold people accountable for any wrongdoing, its CEO said in an email to staff. The email, a copy of which has been reviewed by Reuters, comes after media reported that the...
ISS suggest Enhabit shareholders elect three AREX Capital nominees to board
ISS suggest Enhabit shareholders elect three AREX Capital nominees to board
Jul 11, 2024
July 11 (Reuters) - Institutional Shareholder Services (ISS) on Thursday said Enhabit ( EHAB ) shareholders should elect three AREX Capital Management director candidates to the nine member board, arguing the company needs more expertise in home health, hospice and public company financial reporting. The prominent proxy advisory firm, whose recommendations often guide shareholder votes on proposed mergers and who...
Copyright 2023-2026 - www.financetom.com All Rights Reserved